Cargando…
Personalized medicine in Type 2 Diabetes
Type 2 diabetes (T2D) is a global public health concern, its prevalence in Asia, especially Taiwan, rising every year. The risk of developing T2D and diabetes complications is not only controlled by environmental but also by genetic factors. Genetic association studies have shown polymorphisms at sp...
Autores principales: | Liao, Wen-Ling, Tsai, Fuu-Jen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
China Medical University
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4264975/ https://www.ncbi.nlm.nih.gov/pubmed/25520921 http://dx.doi.org/10.7603/s40681-014-0008-z |
Ejemplares similares
-
NT5C2 methylation regulatory interplay between DNMT1 and insulin receptor in type 2 diabetes
por: Chen, Yng-Tay, et al.
Publicado: (2020) -
Author Correction: NT5C2 methylation regulatory interplay between DNMT1 and insulin receptor in type 2 diabetes
por: Chen, Yng‑Tay, et al.
Publicado: (2021) -
Inhibition of DNA methyltransferase 1 increases nuclear receptor subfamily 4 group A member 1 expression and decreases blood glucose in type 2 diabetes
por: Chen, Yng-Tay, et al.
Publicado: (2016) -
PTPRD silencing by DNA hypermethylation decreases insulin receptor signaling and leads to type 2 diabetes
por: Chen, Yng-Tay, et al.
Publicado: (2015) -
Urine proteome analysis by C(18) plate–matrix-assisted laser desorption/ionization time-of-flight mass spectrometry allows noninvasive differential diagnosis and prediction of diabetic nephropathy
por: Chen, Chao-Jung, et al.
Publicado: (2018)